The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies in patients with prostate cancer.

Somovilla Víctor, Bermejo Iris, Albuquerque Inês, Martínez-Sáez Nuria, Castro-López Jorge, Garcia Martin Fayna, Compañón Ismael, Hinou Hiroshi, Nishimura Shin-Ichiro, Jiménez-Barbero Jesús, Asensio Juan, Avenoza Alberto, Busto Jesús, Hurtado-Guerrero Ramon, Peregrina Jesús, Bernardes Gonçalo, Corzana Francisco. The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies in patients with prostate cancer. JACS, 2017. doi: 10.1021/jacs.7b09447.